Zacks23d agoneutral
5 Stocks to Grab as Manufacturing Activity Hits Four-Year HighAIT, DOV, HUBB, RBC and TRMB stand out as manufacturing activity hits a four-year high amid seven months of sector growth.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
230last 24h
1242last 7d
194● bullish (7d)
123● bearish (7d)
206publishers
Motley Fool23d agoneutral
Want $500 Per Month in Passive Income? This Dividend ETF Can Get You There.This rock-solid dividend ETF proved it can deliver durable income over time.
Zacks23d agoneutral
Shopify (SHOP) Surpasses Q2 Earnings and Revenue EstimatesShopify (SHOP) delivered earnings and revenue surprises of +7.69% and +4.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Barchart23d agoneutral
Nio Hit Record Vehicle Deliveries in July. This Could Be a Real Turning Point for NIO Stock.Nio delivered a record 35,934 vehicles in July 2026, up 71% since last year, bringing 2026 deliveries to 227,057 units and cumulative volume past 1.22 million.
Motley Fool23d agoneutral
Why D-Wave Stock Fell 25% in JulyInvestors are growing impatient with unprofitable companies.
InvestorsHub23d agoneutral
Circle shares climb after Q2 results, federal bank charter approval and higher guidanceCircle Internet Group (NYSE:CRCL) shares rose around 7% in pre-market trading after the stablecoin issuer reported second-quarter results in line with expectations, secured the first federal bank charter granted to a stablecoin company and raised parts of its full-year outlook. The company also announced that BlackRock, Visa and Mastercard will serve as validators for its upcoming blockchain network.
The Telegraph23d agoneutral
Self-driving Ubers to pick up Londoners within weeksSelf-driving Ubers will be picking up passengers in London within weeks after Transport for London (TfL) awarded them a licence.
Zacks23d agoneutral
Should You Invest in OKLO Stock Before Q2 Earnings Release?As OKLO gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.
Barchart23d agoneutral
Are Wall Street Analysts Bullish on Sandisk Stock?Sandisk has massively outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
Reuters Videos23d agoneutralVIDEO
Novo Nordisk looks to future proof as investors worry over pipeline<body><p>STORY: :: Novo Nordisk</p><p>'''Right now, the market isn't convinced that Novo Nordisk pipeline of experimental drugs is robust enough to fight against Lilly.''</p><p>:: How is Novo Nordisk future proofing as investors worry about pipeline?</p><p>:: August 5, 2026</p><p>:: Maggie Fick, European Pharma Industry Correspondent </p><p>''The drugmaker on Tuesday raised its full year profit and sales outlook, but investors are less focused on the numbers. They did look at the weaker than expected sales for its new Wegovy pill, and they're more focused on what the answer that the company has is to this question of the expirations of the patents for the company's key drugs. ''</p><p>'''So the name of the game now really is the medicines that Novo Nordisk is testing right now in trials. And also on Tuesday, Novo reported a trial failure for one of its next generation obesity drugs, obesity and diabetes drugs, CagriSema, and we think that's part of the reason that shares fell on these announcements.''</p><p>:: What is CEO Mike Doutsdar's response?</p><p>:: Novo Nordisk</p><p>''So Mike Doustdar acknowledged these recent trials setbacks, but he argued that they don't change the company's strategy. He says the answer is to move faster in research. He's been at the helm of the company now for a year. And he said one of the important steps he took was to combine research and development under one executive, and that that is helping that department move faster with trials. And he continues to say that failures are part of the pharmaceutical industry, that, trials are run with risks and so this is not unusual and they just have to keep moving. He said that it's important for Novo to stick to its strategy of bolt-on acquisitions to complement its own research and development. And he stressed that a transformational acquisition, a big merger, is not something on his agenda and that's for companies that have big problems.''</p></body>
Investor's Business Daily23d agoneutral
Eli Lilly's Diabetes And Obesity Drugs Blow Past Expectations; Shares PopEli Lilly stock jumped Wednesday on a solid beat-and-raise thanks to its GLP-1 drugs, treatments for diabetes and obesity.
Zacks23d agoneutral
Here's What Could Help Aehr Test Systems (AEHR) Maintain Its Recent Price StrengthIf you are looking for stocks that are well positioned to maintain their recent uptrend, Aehr Test Systems (AEHR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
InvestorsHub23d agoneutral
CDW shares fall despite second-quarter earnings and revenue beatCDW Corporation (NASDAQ:CDW) reported second-quarter results that exceeded Wall Street expectations for both earnings and revenue, but shares dropped more than 8% in pre-market trading as investors focused on weaker margins and higher restructuring costs. The technology solutions provider posted adjusted earnings of $2.
GuruFocus.com23d agoneutral
SpaceX Could Attempt Historic Catch This MonthSpaceX Eyes Major Starship Milestone With First Attempt at Landing the Upper Stage
Zacks23d agoneutral
Tap These 5 Bargain Stocks With Attractive EV-to-EBITDA RatiosPKX, PARR, SBH, BIP and DINO stand out with attractive EV-to-EBITDA ratios and strong earnings outlook.
GuruFocus.com23d agoneutral
Rocket Lab Shares Rise After $397 Million Space Force ContractRocket Lab Lands $397 Million Space Force Contract
Barrons.com23d agoneutral
S&P 500 and Dow Futures Eye New Records While Tech Gains LagS&P 500 and Dow Jones Industrial Average futures were on track to set another record high ahead of Wednesday's opening bell. Nasdaq 100 futures were also in the green, but lagged S&P 500 and Dow futures' gains.
Wards Auto23d agoneutral
Unifor is playing ‘the long game’ in contract talks — and wants automakers to do the sameIn an exclusive interview with WardsAuto, Unifor National President Lana Payne shares her takeaways from recent negotiations with Ford — and what’s ahead.
The Wall Street Journal23d agoneutral
Bond Yields Hold Declines After Treasury Maintains Borrowing GuidanceTreasury yields held earlier overnight declines after the Treasury Department signaled–again–that it has no plans to increase the sizes of note-and-bond auctions for “at least the next several quarters.” The Treasury’s guidance, made as part of its quarterly refunding announcement, was the same that it has made for the past 11 quarters dating back to the start of 2024.
Schaeffer's Investment Research23d agoneutral
What Happens When Stock Implied Volatility Outpaces the SPYIndividual stocks are sporting unusually high IV relative to the SPY
MT Newswires23d agoneutral
Market Chatter: Morgan Stanley-Led Group Plans $15 Billion Bond Sale for Google-Backed Anthropic Data CenterMorgan Stanley (MS) is leading a consortium of banks planning to refinance through bond sales $15 bi
Zacks23d agoneutral
Occidental Petroleum Set to Report Q2 Earnings: How to Play the Stock?OXY is poised for sharp Q2 growth, backed by debt cuts and cash flow, but commodity swings and a premium valuation cloud the setup.
Investing.com23d agoneutral
Jefferies downgrades Best Buy to Hold on slowing demand, memory cost concernsInvesting.com -- Jefferies downgraded Best Buy, a U.S. consumer electronics retailer to Hold from Buy, saying the market already reflects an optimistic outlook for second-quarter comparable sales while earnings upside beyond that could prove more limited amid softer consumer demand and rising cost pressures.
PA Media: Money23d agoneutral
Mounjaro sales double this year as obesity drug boom prevails, says makerThe manufacturer said its obesity medications Mounjaro and Zepbound were driving an acceleration of its overall sales.
GuruFocus.com23d agoneutral
Palantir Stock Massive Jump Wipes Out $3 Billion in Short-Seller GainsPalantir's Huge Rally Turns the Tables on Short Sellers: $3 Billion Loss
Moby23d agoneutral
Private Hiring Stalls in July, Complicating EverythingSoft jobs numbers like these used to start the rate-cut conversation, but this Fed is already looking to raise, and soon
Motley Fool23d agoneutral
Peter Lynch Turned Fidelity Magellan From $18 Million Into $14 Billion With a 29% Annual Return. Here's Whether His "Invest in What You Know" Strategy Still Works Today.Lynch's run from 1977 to 1990 is viewed as one of the best ever.
Motley Fool23d agoneutral
Arista Networks Just Delivered Its First $3 Billion Quarter. Here's What It Means for the AI Networking Trade.AI networking demand keeps accelerating. But how much of it is already in the stock's price?